Pieris Pharmaceuticals
PIRS
$9.81
Share price
5.83%
Change (1 day)
5,671.00%
Change (1 year)
Categories
Pieris Pharmaceuticals (PIRS) - Total debt
Total debt on the balance sheet as of September 2023 : $12.29 M
According to Pieris Pharmaceuticals's latest financial reports the company's total debt is $12.29 M. A company’s total debt is the sum of all current and non-current debts.
Pieris Pharmaceuticals - Total debt on balance sheet (from 2013 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2022-12-31 | $13.1 M | -12% |
| 2021-12-31 | $14.89 M | -12.22% |
| 2020-12-31 | $16.96 M | 4.59% |
| 2019-12-31 | $16.21 M | |
| 2018-12-31 | $N/A | |
| 2014-12-31 | $1.27 M | -73.25% |
| 2014-06-30 | $0 M | 0% |
| 2013-12-31 | $4.75 M | |
| 2013-06-30 | $0 M |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Gilead Sciences GILD | $25.19 B | 204,862.58% | 🇺🇸 USA |
 Flexion Therapeutics
FLXN | N/A | N/A | 🇺🇸 USA |
 Aeterna Zentaris AEZS | $0.23 M | -98.10% | 🇺🇸 USA |